Torsemide Use in Chronic Kidney Disease

Electrolyte Monitoring and Management

• The KDIGO 2021 guidelines recommend monitoring for hypokalemia with thiazide and loop diuretics, as well as monitoring for impaired GFR during diuretic therapy, and watching for volume depletion, especially in elderly patients 1, 2, 3, 4
• The KDIGO 2021 guidelines emphasize the importance of monitoring electrolyte levels, including potassium, sodium, and magnesium, to prevent hypokalemia, hyponatremia, and metabolic alkalosis 1, 2, 3, 4

Combination Therapy Strategy

• The KDIGO 2021 guidelines recommend adding mechanistically different diuretics, such as thiazide diuretics, amiloride, or spironolactone, for synergistic effect when torsemide alone provides inadequate diuresis 1, 2, 3, 4
• Thiazide diuretics can be added to impair distal sodium reabsorption, while amiloride may improve edema/hypertension while countering hypokalemia, and spironolactone provides additional benefit and prevents potassium loss 1, 2, 3, 4

Dietary Sodium Restriction

• The KDIGO 2021 guidelines recommend restricting dietary sodium to <2.0 g/day (<90 mmol/day) to maximize diuretic efficacy, permitting the use of lower, safer diuretic doses 1, 2, 3, 4

Diuretic-Resistant Edema Management

• The KDIGO 2021 guidelines provide a structured approach for managing diuretic-resistant edema, including increasing torsemide dose progressively, adding amiloride to reduce potassium loss and improve diuresis, considering acetazolamide for metabolic alkalosis, combining loop diuretics with IV albumin, and considering ultrafiltration or hemodialysis for refractory cases 1, 2, 3, 4

Common Pitfalls to Avoid

• Failing to restrict dietary sodium undermines diuretic effectiveness and necessitates higher, potentially toxic doses, as recommended by the KDIGO 2021 guidelines 1, 2, 3, 4